Dr. Mark C. Liu

Dr. Neptune is a pulmonary, critical care physician with expertise in genetic disorders of the matrix with pulmonary manifestations. She is also skilled in the management of patients with advanced obstructive lung disease, especially emphysema. Dr. Neptune has extensive expertise in the diagnosis and management of the pulmonary complications of Marfan Syndrome, Loeys-Dietz Syndrome, vascular Ehlers Danlos Syndrome and other matrix disorders and serves on the Professional Advisory Board of the Marfan Foundation. She is also an expert on tobacco dependence and is the Vice-Chair of the Tobacco Action Committee of the American Thoracic Society. Dr. Neptune earned her M.D. from Harvard Medical School. She completed her residency and performed a fellowship in pulmonary and critical care at the University of California, San Francisco. She also performed a fellowship in genetics at Johns Hopkins. Her research interests include therapeutic strategies in Marfan syndrome; mechanisms and prevention of progression of COPD; and hepatocyte growth factor signaling in airspace homeostasis. Dr. Neptune is committed to creating a diverse research community and clinical workforce. She is involved in multiple diversity initiatives at Johns Hopkins and the American Thoracic Society. She is also involved in increasing awareness of tobacco dependence and the needed regulatory policies. Dr. Neptune serves on the Compliance Compensation Subcommittee for the Department of Medicine. Dr. Neptune is rated as an Advanced provider by MediFind in the treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome). Her top areas of expertise are Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome), Acute Interstitial Pneumonia, Interstitial Lung Disease, and Emphysema.

Dr. Wise is a pulmonary, critical care physician. He is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. He is a consultant for patients with scleroderma and interstitial lung disease. He has expertise in pulmonary physiology and lung function testing. Dr. Wise’s research focus is the conduct of multi-center clinical trials in airway diseases and related translational research. Dr. Wise is the co-director of the Pulmonary T32 Multi-disciplinary Training Program in Pulmonary Disease. Dr. Wise is rated as a Distinguished provider by MediFind in the treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome). His top areas of expertise are Systemic Sclerosis (SSc), Interstitial Lung Disease, Acute Interstitial Pneumonia, and Sarcoidosis.

Graduate of Harvard College, Weill Cornell Medical College of Cornell University. Residency in Medicine at Johns Hopkins Hospital. Fellowship in Pulmonary and Critical Care Medicine, Brigham and Women''s Hospital and Harvard Medical School. Research Fellowship in Respiratory Biology, Harvard School of Public Health. Private Practice, Pulmonologists PC of Montgomery County, MD since 1988. Special interest in sleep medicine. Clinical Professor of Medicine, George Washington Univ. School of Medicine since 2005. President, DC Thoracic Society, Washington DC 2014-2015. Volunteer Physician, Mercy Health Clinic, Gaithersburg MD. Member, Board of Directors, Mercy Health Clnic, 2013-15. Faculty leader, Hait mobile health clinics, Project Medishares and G.W. International Medicine, 2012- . Videos 2016 Armstrong Award for Excellence in Quality and Safety - Steven Kariya, M.D., Suburban Hospital. Dr. Kariya is rated as a Distinguished provider by MediFind in the treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome). His top areas of expertise are Asthma in Children, Asthma, Lung Metastases, and Chronic Obstructive Pulmonary Disease (COPD).